• For investors wondering whether Teradyne at around US$365 a share still offers value or if most of the opportunity is already priced in, this article walks through what the numbers indicate about the stock.
• The share price has been volatile, with returns of 14.1% over the last week, 27.6% over the last month, 76.1% year to date, and 395.4% over the past year. This context can change how you think about both upside and risk.
• Recent attention on Teradyne has focused on its role within the semiconductor space and its exposure to areas such as test equipment for advanced chips, which can influence how investors frame growth potential and cyclicality. News and commentary around sector demand, capital spending by chipmakers, and automation trends provide important context for the recent share price movements.
• Despite this strong share price performance, Teradyne currently has a valuation score of 0 out of 6. The next sections will walk through different valuation approaches and then conclude with a way to tie them together into a fuller picture of what the stock might be worth.

Teradyne scores just 0/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Teradyne Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model looks at the cash Teradyne is expected to generate in the future and discounts those projected cash flows back to a single value today. It is essentially an attempt to answer what all those future dollars are worth in today’s terms.

For Teradyne, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month free cash flow is about $460.8 million. Analysts and model estimates project free cash flow rising to $2,050.1 million by 2030, with interim annual estimates and extrapolated values between now and then provided by Simply Wall St.

When those projected cash flows are discounted back and aggregated, the model arrives at an estimated intrinsic value of about $174.05 per share. With the current share price around $365, the DCF output implies the stock is roughly 110.0% above this estimate. This points to Teradyne trading at a rich premium on this cash flow view.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Teradyne may be overvalued by 110.0%. Discover 57 high quality undervalued stocks or create your own screener to find better value opportunities.

Approach 2: Teradyne Price vs Earnings

For profitable companies, the P/E ratio is a useful way to link what you pay for each share to what the business is currently earning. It helps you see how many dollars of price you are paying for each dollar of earnings, which is often a simple starting point when profits are positive.

What counts as a “normal” P/E depends on how fast earnings are expected to grow and how risky those earnings are. Higher expected growth and lower perceived risk can justify a higher P/E, while slower growth or higher uncertainty usually line up with a lower P/E.

Teradyne currently trades on a P/E of 103.28x. That is above both the Semiconductor industry average of 42.24x and the peer average of 58.02x. Simply Wall St’s “Fair Ratio” for Teradyne is 42.16x, which is a proprietary estimate of what the P/E might be given factors such as earnings growth, profit margins, industry, market cap and company specific risks. This fair ratio is more tailored than a simple comparison to peers or the broad industry because it adjusts for those company level characteristics.

Compared with this Fair Ratio of 42.16x, the current P/E of 103.28x suggests Teradyne is trading at a rich premium on this metric.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your Teradyne Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives are a way for you to attach a clear story about Teradyne to the numbers you see, by linking your view on its future revenue, earnings and margins to a financial forecast and then to a fair value that you can compare with the current share price.

On Simply Wall St’s Community page, Narratives are available as an accessible tool used by millions of investors. You can see and refine scenarios such as a more optimistic view that aligns with a fair value of about US$376.32, a consensus style view closer to US$307.41, a cautious view around US$141.40, or even a bearish US$74.00. You can then judge for yourself whether Teradyne’s current price looks high or low against the fair value that fits your story.

Because these Narratives are updated when new information comes in, such as changes to analyst earnings paths, new guidance, product announcements or joint ventures, you can see how fresh news or results shift fair value and decide whether that moves Teradyne closer to your “buy”, “hold” or “sell” zone based on the Narrative you believe is most realistic.

For Teradyne however, we will make it really easy for you with previews of two leading Teradyne Narratives:

Fair value in this bullish Narrative: about US$376.32 per share.

Implied discount to that fair value versus the last close around US$365.51: roughly 3% below this Narrative fair value.

Revenue growth assumption in this scenario: about 30.3% a year.

• Assumes Teradyne builds on its position in advanced chip test and robotics as AI spending and automation trends support higher volumes and pricing.
• Factors in a strong balance sheet, ongoing product development and share buybacks as support for earnings quality and cash generation.
• Recognises risks around exposure to cyclical chip capex, geopolitical and regulatory uncertainty, and pressure from lower cost competitors and internal test solutions.

Fair value in this more cautious Narrative: about US$307.41 per share.

Implied premium to that fair value versus the last close around US$365.51: roughly 19% above this Narrative fair value.

Revenue growth assumption in this scenario: about 22.7% a year.

• Assumes Teradyne benefits from AI test, robotics and semiconductor automation, but with more moderate revenue and margin expectations than the bullish view.
• Builds in earnings support from acquisitions and share buybacks, while keeping a lid on the valuation multiple applied to those future earnings.
• Flags ongoing uncertainty from tariffs, trade policy, robotics softness and potential swings in gross margin if product mix or HBM related demand shifts.

The gap between these Narratives shows you how different assumptions on growth, profitability and valuation can move fair value for the same stock, and it gives you a clear range to test against your own expectations for Teradyne.

Do you think there's more to the story for Teradyne? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.